For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Low Dose Vancomycin | Vancomycin 125 mg 4 times a day | None | None | 0 | 8 | 4 | 8 | View |
| High Dose Vancomycin | Vancomycin 250 mg 4 times a day | None | None | 0 | 9 | 3 | 9 | View |
| Low Dose Metronidazole | Metronidazole 250 mg 3 times a day | None | None | 0 | 9 | 6 | 9 | View |
| High Dose Metronidazole | metronidazole 500 mg 3 times a day | None | None | 0 | 9 | 8 | 9 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| metallic taste | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| burning in eyes | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| increased bilirubin | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| increased itching | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| anorexia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| numbness and tingling of extremities | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| stomach pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| weight loss | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| increased fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| malaise | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| vertigo | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| headaches | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |